Artificial Intelligence | Machine Learning InterVenn Biosciences | Unique, Powerful Liquid Biopsy Platform


Enterprise, Biotech, Healthcare, Biomarkers, Cancer Detection, Cancer Treatment, Drug Discovery, Glycoproteomics South San Francisco , California , United States

InterVenn Biosciences

Artificial Intelligence | Machine Learning


InterVenn Biosciences | Unique, Powerful Liquid Biopsy Platform

InterVenn Biosciences

Biotech, Healthcare, Biomarkers, Cancer Detection, Cancer Treatment, Drug Discovery, Glycoproteomics


South San Francisco , California , United States

InterVenn Biosciences utilizes a proprietary high-throughput glycoproteomic interrogation platform using artificial intelligence and mass spectrometry for next-gen precision medicine. The company is working to find new solutions in ovarian, pancreatic, liver, prostate, and kidney cancer, together with applications from the Vista suite of solutions for treatment and monitoring, immune profiling, patient stratification, and disease progression.

 

B2B

101 to 250

N/A

N/A

Scaling Up

2017

 
 

Healthcare
Biotechnology

N/A

N/A

 
 

Production
Service

Yes

Active

 
 

   Machine Learning


Early Cancer Detection Tool

Early Cancer Detection Tool


N/A

 

   Software


GitHub

GitHub

Linux

Linux

R

R

AWS Cloud

AWS Cloud

Google Cloud

Google Cloud

Tensorflow

Tensorflow

Pytorch

Pytorch

Python

Python


Machine Learning Algorithm

Machine Learning Algorithm

 
 

Jun 2021

  • InterVenn Biosciences Announces Clinical Validation of World’s First Glycoproteomic Diagnostic Test

Apr 2021

  • InterVenn Biosciences Announces that Nobel Laureate James P. Allison, PhD, has Joined the Company’s Board of Advisors
 
 

6

1

$201M

Company was founded 2017 and it took almost 4 years (Aug 2021) to raise first external round

 
 

Date

Round

$ Raised

Investors

08/02/2021

Series C

$201M

True Ventures, Irving Investors, Heritage Provider Network, Jenny Rooke, Anzu Partners, Amplify Partners

Date : 08/02/2021

Round: Series C

$ Raised: $201M

Investors: True Ventures, Irving Investors, Heritage Provider Network, Jenny Rooke, Anzu Partners, Amplify Partners

 

Investors

Interested in researching InterVenn Biosciences?

We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about InterVenn Biosciences

Request a Demo - Deal Souring Platform

 
 Aldo Carrascoso


Aldo Carrascoso
CEO and Co-Founder

Randolph Barr


Randolph Barr
Chief Information & Security Officer

Melanie Barr


Melanie Barr
Human Resources Manager

Rj Covington


Rj Covington
Senior Talent Acquisition Partner

Gavin Haney


Gavin Haney
Senior Director of Marketing

Maryam Hosseini


Maryam Hosseini
Vice President of Operations

 
 

Potential Customers

Interested in what they do or partnership?

Learn more about how they work

Schedule a Call w/ InterVenn Biosciences